Merck Mulls Sale, Partnership Options for Consumer Health Unit

By Nathan Allen Features Dow Jones Newswires

Germany's Merck KGaA (MRK.XE) said Tuesday it is considering strategic options for its consumer health unit, including a full or partial sale, or a strategic partnership.

Continue Reading Below

In a statement, the pharmaceutical and specialty-chemicals company said proceeds from the potential transaction would be used to deliver overall financial targets. A final decision hasn't been made.

The consumer health unit, which manufactures over-the-counter drugs, generated sales of 860 million euros ($1.02 billion) in 2016 from a portfolio of 10 core brands that serve more than 40 markets.

Write to Nathan Allen at nathan.allen@dowjones.com

(END) Dow Jones Newswires

September 05, 2017 03:58 ET (07:58 GMT)